Evidence map›Paper›PMID 40171189›Full record

ArticleFrontiers in endocrinology2025

Levodopa induces thyroid function regulation in a patient with thyroid hormone resistance and Parkinson's disease: a case report.

Gabriela Rozo-Paz, Clara Maria Ruiz-Forero, José David Suárez-Mera, Guillermo Monsalve Duarte, William Kattah Calderón

Abstract readCase Reports
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gabriela Rozo-PazUniversidad de Los Andes, Bogotá, Colombia.
Clara Maria Ruiz-ForeroUniversidad Cooperativa de Colombia, Villavicencio, Colombia.
José David Suárez-MeraFundación Santa Fé de Bogotá, Bogotá, Department of Pathology, Bogotá, Colombia.
Guillermo Monsalve DuarteFundación Santa Fé de Bogotá, Bogotá, Department of Neurological Surgery, Bogotá, Colombia.
William Kattah CalderónFundación Santa Fé de Bogotá, Department of Endocrinology, Bogotá, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Thyroid hormone resistance (THR) is a rare genetic syndrome characterized by reduced sensitivity to thyroid hormones. Patients may be asymptomatic, although clinical manifestations depend on the THR subtype. This entity commonly has abnormal thyroid function tests and can be confirmed by molecular analyses. Case presentation: The present study describes a 55 year-old female diagnosed with surgically resected papillary thyroid carcinoma. During the endocrinology consults, elevated thyroid hormone levels were detected without an adequate TSH response, and THR was suspected. Moreover, Parkinson's disease was diagnosed, and treatment with levodopa/carbidopa was initiated. Following this regimen, her TSH and total T3 levels were subsequently normalized, which suggests a potential effect of this agent on the normalization of these hormone levels in the blood. In this case, the role of levodopa was crucial to regulate the TSH concentration which was required to carry out the resection of a tumoral remnant. Conclusion: The influence of dopamine in the endocrine system, specifically in the thyroid gland, is beneficial in conditions such as THR where abnormal TSH levels can be lowered, helping to balance the thyroid and hormones function.

Indexed as

LevodopaParkinson DiseaseThyroid GlandThyroid Hormone Resistance SyndromeCarbidopaFemaleHumansMiddle AgedThyroid Function TestsThyroid NeoplasmsThyrotropinCarbidopaLevodopaThyrotropincase reportdopaminelevodopaParkinson’s diseasethyroid hormone resistance

Identifiers

PMID40171189
PMCPMC11958178

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.